Literature DB >> 25243343

Examining strategies to improve accelerometer compliance for individuals living with schizophrenia.

Paul Gorczynski1, Guy Faulkner2, Tony Cohn3, Gary Remington4.   

Abstract

OBJECTIVE: This study examined the feasibility and effect of 2 investigator-based and 2 participant-based strategies on accelerometer wear time in individuals living with schizophrenia in order to improve accelerometry compliance.
METHOD: Four adults with schizophrenia were asked to wear an accelerometer for 1 week during the baseline, intervention, and follow-up phases of a study that evaluated exercise counseling. To encourage participants to wear their accelerometers, investigators modeled proper accelerometer use, provided verbal and written instructions, and placed reminder phone calls. Participants were also given wear time logs and reminder magnets.
RESULTS: All participants wore their accelerometers for the required amount of time during the study. CONCLUSIONS AND IMPLICATIONS FOR PRACTICE: Researchers should use multiple techniques to help ensure compliance. Research is needed to identify the most effective combination of strategies for this population. (c) 2014 APA, all rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25243343     DOI: 10.1037/prj0000093

Source DB:  PubMed          Journal:  Psychiatr Rehabil J        ISSN: 1095-158X


  2 in total

1.  Impact of different recruitment strategies on accelerometry adherence and resulting physical activity data: A secondary analysis.

Authors:  Kevin Rudolf; Christopher Grieben; Katja Petrowski; Ingo Froböse; Andrea Schaller
Journal:  Prev Med Rep       Date:  2018-02-21

2.  The Validity and Value of Self-reported Physical Activity and Accelerometry in People With Schizophrenia: A Population-Scale Study of the UK Biobank.

Authors:  Joseph Firth; Brendon Stubbs; Davy Vancampfort; Felipe B Schuch; Simon Rosenbaum; Philip B Ward; Josh A Firth; Jerome Sarris; Alison R Yung
Journal:  Schizophr Bull       Date:  2018-10-17       Impact factor: 9.306

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.